Jon Rappoport: New level of COVID fakery; I’m doubling

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28 cashclan #75373
336
Jon Rappoport: New level of COVID fakery; I’m doubling down

https://blog.nomorefakenews.com/2022/01/07/ne...ling-down/

By Jon Rappoport
January 7, 2022

I’m expanding the claim I’ve made in several recent articles.

I wrote that, by accepting current statistics on COVID cases in the US, you’re committed to concluding that everyone in America is going to be infected.

That was an UNDERESTIMATE.

If you accept the official figures—56 million COVID cases since the beginning of the pandemic, and one million new cases on the day of January 3rd—you’re committed to this:

Not only will all 330 million people in the US become infected, everyone in a nation of a billion people would become infected.

In the US, with 330 million people, everyone would become infected five, six, or seven times.

No matter what.

—Regardless of vaccines, quarantines, isolation, lockdowns, distancing, masks, everyone moving to underground bunkers and permanently wrapping themselves in stitched-together plastic shower curtains.

If you accept the existence of the virus, the supposed extent and speed of its rapid spread, the validity of the test, the accuracy of the case numbers, the meaning of what constitutes a case, you’re committed to:

EVERYONE GETS INFECTED AT LEAST HALF-A-DOZEN TIMES.

It’s really worse, because the official reports on the virus imply it’s behaving unlike any other germ in history. It’s not burning out. Natural immunity isn’t taking hold.

Therefore, everyone will become infected and re-infected an UNLIMITED number of times. And if naturally acquired immunity doesn’t take hold in the future, we’re all going to die.

That’s the actual COVID narrative, once you accept the basic premises.

Face it.

Or do something revolutionary: think about the basic premises.

For the past two years, I’ve written over 450 articles rejecting every single premise, with explanations and evidence.

And when I say “every premise,” I include the fatuous and bloated and preposterous and kindergarten assertion that the virus—SARS-CoV-2—exists.

Because it doesn’t. The virus doesn’t exist.

Once you extract that rotting piece of nonsense from the COVID story, all the other premises, and the whole narrative, collapse.

Sanity returns.

Of course, I’m aware that many people prefer to remain blindly insane. They prefer to accept the official COVID fairy tale, while at the same time refusing to realize the implications of what they are buying.

I’m not writing for them.

I’m not writing for the people who hold out hope that “a vaccine will save us.” Think that through. In the last year, we’ve seen two significant variant strains of the virus, according to the lying public health leadership. If that were true, we would expect to see more variants—and the vaccine would stop working each time a new variant appeared. As one researcher recently pointed out, are we supposed to believe the whole country (and the world) can be injected with a useful booster EVERY SIX MONTHS?

Of course, there are no variants, because there is no virus. There is nothing to vary FROM.

Everywhere you look, the official story implies doom, and everywhere you look, the official story is false.

Here is another article I wrote about the virus that isn’t there:

CDC/FDA smoking gun of smoking guns.

They confess: they had no virus when they concocted the test for the virus; they “contrived” a model by pretending to find what they wanted to find; it’s called a self-fulfilling prophecy.

This is the con and the crime that drove millions of lives, and economies, into ruin.

The CDC has issued a document that bulges with devastating admissions.

The release is titled, “07/21/2021: Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing.” ( https://bit.ly/34uVHYy ) It begins explosively:

“After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.”

CDC/FDA are confessing there has been a PROBLEM with the PCR test which has been used to detect the virus, starting in February of 2020—right up to this minute.

In other words, the millions and millions of “COVID cases” based on the PCR test in use are all suspect. Actually, that statement is too generous. Every test result of every PCR test should be thrown out.

To confirm this, the CDC document links to an FDA release titled, “SARS-CoV-2 Reference Panel Comparative Data.” ( https://bit.ly/3n7AmdY ) Here is a killer quote:

“During the early months of the Coronavirus Disease 2019 (COVID-19) pandemic, clinical specimens [of the virus] were not readily available to developers of IVDs [in vitro diagnostics] to detect SARS-CoV-2. Therefore, the FDA authorized IVDs based on available data from contrived samples generated from a range of SARS-CoV-2 material sources (for example, gene specific RNA, synthetic RNA, or whole genome viral RNA) for analytical and clinical performance evaluation. While validation using these contrived specimens provided a measure of confidence in test performance at the beginning of the pandemic, it is not feasible to precisely compare the performance of various tests that used contrived specimens because each test validated performance using samples derived from different gene specific, synthetic, or genomic nucleic acid sources.”

Translation: We, at the CDC, did not have a specimen of the SARS-CoV-2 virus when we concocted the PCR test for SARS-CoV-2. Yes, it’s unbelievable, right? And that’s the test we’ve been using all along. So we CONTRIVED samples of the virus. We fabricated. We lied. We made up [invented] synthetic gene sequences and we SAID these sequences HAD TO BE close to the sequence of SARS-CoV-2, without having the faintest idea of what we were doing, because, again, we didn’t have an actual specimen of the virus. We had no proof THERE WAS something called SARS-CoV-2.

This amazing FDA document goes to say the Agency has granted emergency approval to 59 different PCR tests since the beginning of the (fake) pandemic. 59. And, “…it is not feasible to precisely compare the performance of various tests that used contrived specimens because each test validated performance using samples derived from different gene specific, synthetic, or genomic nucleic acid sources.”

Translation: Each of the 59 different PCR tests for SARS-CoV-2 told different lies and concocted different fabrications about the genetic makeup of the virus—the virus we didn’t have. Obviously, then, these tests would give unreliable results. THE PCR TESTS USED CONTRIVED SPECIMENS OF THE VIRUS WE DIDN’T HAVE.

BUT, don’t worry, be happy, because NOW, the CDC and the FDA say, they really do have actual virus samples of SARS-CoV-2 from patients.

In other words, they were lying THEN, but they’re not lying NOW. They were “contriving,” but now they’re telling the truth.

If you believe that, I have Fountain of Youth water for sale, extracted from the lead-contaminated system of Flint, Michigan.

Here, once again, I report virology’s version of “we isolated (discovered) the virus”:

They have a soup they make in their labs.

This soup contains human and monkey cells, toxic chemicals and drugs, and all sorts of other random genetic material. Because the cells start to die, the researchers ASSUME a bit of mucus from a patient they dropped in the soup is doing the killing, and THE VIRUS must be the killer agent in the mucus.

This assumption is entirely unwarranted. The drugs and chemicals could be doing the cell-killing, and the researchers are also starving the cells of vital nutrients, and that starvation could kill the cells.

There is no proof that SARS-CoV-2 is in the soup, or that it is doing the cell-killing, or that it exists.

Yet the researchers call cell-death “isolation of the virus.”

To say this is a non-sequitur is a vast understatement. In their universe, “We assume, without proof, we have the virus buried in a soup in a dish in the lab” equals, “We’ve separated the virus from all surrounding material.”

Virology equals “how to spread bullshit for a living and scare the world.” Other than that, it’s perfect.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lititz Mutual Embraces AI with Guidewire ProNavigator

Updated Category News Views 5

It's not every day you see a company like Lititz Mutual making moves in the artificial intelligence (AI) arena. Based out of Lititz, Pennsylvania, this insurance firm has decided to shake things up with Guidewire's ProNavigator AI assistant. Forging New Paths in Insurance Lititz Mutual is set to inject some serious tech into their operations. The goal? Make life easier...

Continue Reading
Castillo Engineering Gears Up with New VP Appointments

Updated Category News Views 1

New Leadership to Drive Expansion In a boost to its commitment to scaling up, Castillo Engineering, based in Maitland, Florida, has roped in two veterans from the renewables sector as vice presidents. Aaron Carrillo and Devin Radovich, who share a history of successful collaboration at Renewable Energy Systems Americas (RES), are set to guide Castillo's growth in the...

Continue Reading
NACD Honors Top Board Leaders with 2026 Awards

Updated Category News Views 11

Celebrating Boardroom Mavericks at NACD Gala September 2026 has brought some sparkling recognition to the elites guiding today's corporate governance landscapes. The National Association of Corporate Directors (NACD) has announced their Directorship 100 honorees, tipping their hats to stellar individuals firing on all cylinders in the boardroom. Who's Getting the Nod?...

Continue Reading
Lawsuit Targets Electrical Consultants' Labor Practices

Updated Category News Views 3

Trouble Brews at Electrical Consultants, Inc. Right on the heels of a long workday, some employees of Electrical Consultants, Inc. seem to be getting a double whammy. The company is tangled up in a class action lawsuit lodged by the well-known Blumenthal Nordrehaug Bhowmik De Blouw LLP. This ain't your everyday grievance, folks; we're talking meal and rest period...

Continue Reading
Anixa Expands Global Footprint with Aussie Patent

Updated Category News Views 3

Breaking New Ground in Cancer Immunotherapy Today feels like a pivotal day for Anixa Biosciences. Their announcement about securing a patent in Australia for their trailblazing breast cancer vaccine is like planting a flag on new, promising territory. This is no minor step; it's a strategic leap for the company as it strengthens its intellectual grip on the global...

Continue Reading
Spencer Peterman Hosts Eco-Friendly Wood Bowl Sale

Updated Category News Views 4

Just when you think you've seen it all in the world of craftsmanship, along comes a dynamo like Spencer Peterman. For over 25 years, he's been turning what others discard into treasures. Fallen trees? Most folks see firewood. Spencer sees a future masterpiece. And now, he’s rolling out the welcome mat for his loyal customers with a special sale that runs until December...

Continue Reading
HNTB Expands in Capital Region: A Strategic Move

Updated Category News Views 2

Breaking New Ground in Arlington and Baltimore Deepening their stake in the Capital Region's future, HNTB has thrown open new office doors in Arlington, Virginia, and Baltimore, Maryland. We're not just talking fancy buildings, folks—this is about securing a piece of the infrastructure pie that's only going to get bigger and tastier. Infrastructure's the backbone of...

Continue Reading
U.N. Leaders Converge at NYSE, Forus Soars to $3B Valuation

Updated Category News Views 3

A Busy Morning at the NYSE with Key Guests and Global Events In a world where high-stakes diplomacy and roaring market bells go hand in hand, today brings the U.S. Secretary of State, Marco Rubio, to the New York Stock Exchange. With the 81st Session of the United Nations General Assembly shaking up the Big Apple, the city finds itself at the intersection of politics and...

Continue Reading
Molex's VersaBeam Mini Pushes AI Data Center Limits

Updated Category News Views 2

Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...

Continue Reading
Annex Brands Grows with Bastrop's PostalAnnex Opening

Updated Category News Views 2

New PostalAnnex Location Opens in Bastrop, TX Here's a fresh chapter in the books for Annex Brands, Inc. They've just cut the ribbon on a brand spanking new PostalAnnex in Bastrop, Texas, handing the reins over to eager fresh faces, Chetan Modi and Karan Desai. And you know what? This ain't just any regular location. It's a one-stop-shop for anything you could need, from...

Continue Reading

Top 5 Most Recently Viewed Articles

Crown Holdings Reports Strong Performance in Q3 2025

Updated Category News Views 257

Crown Holdings Shows Robust Growth in Third Quarter 2025 Crown Holdings, Inc. (NYSE: CCK) has announced impressive financial results for the latest quarter, showcasing its continuing strength in the packaging industry. The company reported strong earnings and positive trends, demonstrating resilience in a competitive market environment. Quarterly Highlights In the third...

Continue Reading
Cyberstar's FedRAMP Authorization: Advancing Cyber Defense Solutions

Updated Category News Views 425

Cyberstar Achieves Full FedRAMP Authorization Cyberstar, an industry leader in providing innovative solutions for cyber workforce modernization, has reached a significant milestone by achieving full authorization on the Federal Risk and Authorization Management Program (FedRAMP) Marketplace. This noteworthy accomplishment enhances the company's offerings in cyber...

Continue Reading
Owens Corning Declares Quarterly Cash Dividend for 2025

Updated Category News Views 162

Owens Corning Declares Quarterly Cash Dividend for 2025 In a significant announcement, Owens Corning (NYSE: OC) has declared a quarterly cash dividend of $0.69 per common share. This decision was made by the company's Board of Directors and reflects the strong financial health of the organization. The dividend is set to be payable on April 10, 2025, for shareholders who...

Continue Reading
Belgravia Hartford Keeps Strong Momentum with New Appointments

Updated Category News Views 139

Belgravia Hartford Announce AGM Outcomes and New Leadership Belgravia Hartford Capital Inc. (CSE: BLGV) is pleased to share significant developments following its recent Annual General Meeting (AGM) with shareholders. During the AGM, shareholders demonstrated robust support with 40.75% of common shares represented either in person or through proxy. This strong...

Continue Reading
Key Insights on Trading Activity of De La Rue plc

Updated Category News Views 123

Understanding the Trading Activities of De La Rue plc In the dynamic world of financial markets, the trading activities of companies are crucial indicators for investors. One of the recent disclosures has shed light on the transactions involving De La Rue plc, a prominent player in the currency and security printing sector, highlighting the role of its associated exempt...

Continue Reading